PPB - Services

Complaints, Feedback and Enquiry

Dexamethasone in the Management of Covid-19 Patients

[featured_image]
  • Version 1
  • Download 49
  • File Size 115 KB
  • File Count 1
  • Create Date February 24, 2022
  • Last Updated February 24, 2022

Dexamethasone in the Management of Covid-19 Patients

The Pharmacy and Poisons Board "The Board" advises against self-medication and stock piling of dexamethasone of any other medicine suggested to cure covid-19, The use of Dexamethasone in the management of COVID9-19 is STRICTLY for patients who are hospitalized with acute respiratory distress and on respiratory support.

Attached Files

FileAction
PUBLIC STATEMENT.jpegDownload

Author

ppb_admin

Leave a comment

Your email address will not be published.